Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 7—July 2017
Research

Nontuberculous Mycobacteria Infections at a Provincial Reference Hospital, Cambodia

Maryline BonnetComments to Author , Kim Chamroeun San, Yati Pho, Chandara Sok, Jean-Philippe Dousset, William Brant, Northan Hurtado, Khun Kim Eam, Elisa Ardizzoni, Seiha Heng, Sylvain Godreuil, Wing-Wai Yew, and Cathy Hewison
Author affiliations: TRANSVIHMI IRD, INSERM, University of Montpellier, Montpellier, France (M. Bonnet); Epicentre, Paris, France (M. Bonnet, Y. Pho); Médecins Sans Frontières, Paris (K. Chamroeun San, C. Sok, J.-P. Dousset, N. Hurtado, E. Ardizzoni, C. Hewison); University of Virginia, Charlottesville, Virginia, USA (W. Brant); National Center for Tuberculosis and Leprosy Control, Phnom Penh, Cambodia (K.-K. Eam); Institute of Tropical Medicine, Antwerp, Belgium (E. Ardizzoni); Institut Pasteur, Phnom Penh (S. Heng); INSERM, University of Montpellier, Montpellier (S. Godreuil); Chinese University of Hong Kong, Hong Kong, China (W.-W. Yew)

Main Article

Table 2

Clinical presentation of patients in a study of NTM infections at Kampong Cham Provincial Reference Hospital, Cambodia, October 1, 2012–April 21, 2014*

Characteristic Total, N = 1,187 TB, n = 217 NTM disease, n = 11 NTM colonization, n = 113 Culture-negative, n = 842
Temperature >37.5°C
115 (9.7)
32 (14.7)
2 (18.2)
9 (8.0)
72 (8.5)
Median BMI, kg/m2 (IQR) 19.0 (17.0–21.5) 18.1 (16.2–19.8) 14.8 (13.9–16.2) 18.8 (16.9–20.9) 19.4 (17.2–22.1)
BMI <18.5
524 (44.1)
123 (56.7)
10 (90.9)
52 (46.0)
337 (40.0)
Karnofsky, % (IQR) 90 (90–100) 90 (80–100) 80 (80–90) 90 (90–100) 90 (90–100)
SaO2, % (IQR) 98 (97–99) 98 (97–99) 99 (91–100) 98 (97–99) 98 (97–99)
Cough 1,185 (99.8) 217 (100) 11 (100) 113 (100) 840 (99.8)
Duration, wks (IQR) 4 (3–12) 8 (4–12) 8 (2–20) 4 (3–10) 4 (3–12)
Chest pain 501 (42.2) 106 (48.8) 7 (63.6) 45 (39.8) 343 (40.6)
Hemoptysis 151 (12.7) 27 (12.4) 0 16 (14.2) 108 (12.8)
Dyspnea 563 (47.4) 118 (54.4) 7 (63.6) 46 (40.7) 392 (46.6)
Loss of appetite 300 (25.3) 63 (29.0) 5 (45.4) 27 (23.9) 205 (24.3)
Loss of weight 753 (63.4) 182 (83.9) 9 (81.8) 62 (54.9) 499 (59.3)
Fatigue 151 (12.7) 44 (20.3) 4 (36.7) 10 (8.8) 93 (11.0)
Pleural effusion 18 (1.5) 3 (1.4) 0 1 (0.9) 14 (1.7)
Adenopathy 5 (0.4) 1 (0.5) 0 0 4 (0.5)

*Values are no. (%) patients except as indicated. IQR, interquartile range; NTM, nontuberculous mycobacteria; TB, tuberculosis.

Main Article

Page created: June 19, 2017
Page updated: June 19, 2017
Page reviewed: June 19, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external